Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $73.35 million. The enterprise value is $52.24 million.

Market Cap	73.35M
Enterprise Value	52.24M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RLMD has 33.19 million shares outstanding. The number of shares has increased by 2.87% in one year.

Current Share Class	33.19M
Shares Outstanding	33.19M
Shares Change (YoY)	+2.87%
Shares Change (QoQ)	+9.15%
Owned by Insiders (%)	11.66%
Owned by Institutions (%)	16.08%
Float	23.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.45
P/TBV Ratio	4.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.11

Current Ratio	4.11
Quick Ratio	4.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -175.12% and return on invested capital (ROIC) is -113.84%.

Return on Equity (ROE)	-175.12%
Return on Assets (ROA)	-95.67%
Return on Invested Capital (ROIC)	-113.84%
Return on Capital Employed (ROCE)	-441.28%
Revenue Per Employee	n/a
Profits Per Employee	-$3.99M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.29% in the last 52 weeks. The beta is 0.92, so RLMD's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-39.29%
50-Day Moving Average	1.58
200-Day Moving Average	0.74
Relative Strength Index (RSI)	59.28
Average Volume (20 Days)	347,708

Short Selling Information

The latest short interest is 835,693, so 2.52% of the outstanding shares have been sold short.

Short Interest	835,693
Short Previous Month	711,326
Short % of Shares Out	2.52%
Short % of Float	3.63%
Short Ratio (days to cover)	0.94

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-70.52M
Pretax Income	-67.81M
Net Income	-67.81M
EBITDA	n/a
EBIT	-70.52M
Earnings Per Share (EPS)	-$2.19

Balance Sheet

The company has $20.62 million in cash and n/a in debt, giving a net cash position of $20.62 million or $0.62 per share.

Cash & Cash Equivalents	20.62M
Total Debt	n/a
Net Cash	20.62M
Net Cash Per Share	$0.62
Equity (Book Value)	15.95M
Book Value Per Share	0.48
Working Capital	15.96M

Cash Flow

Operating Cash Flow	-49.92M
Capital Expenditures	n/a
Free Cash Flow	-49.92M
FCF Per Share	-$1.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.87%
Shareholder Yield	-2.87%
Earnings Yield	-93.07%
FCF Yield	-68.53%

Analyst Forecast

The average price target for RLMD is $1.00, which is -54.75% lower than the current price. The consensus rating is "Hold".

Price Target	$1.00
Price Target Difference	-54.75%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-23.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.

Last Split Date	Sep 30, 2019
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1